Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial

Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial

IntroductionThe Chinese herbal compound formula, Shenqisuxin granule (SQSX), promotes neovascularization and prevents in-stent restenosis in modern pharmaceutical studies and is expected to provide an effective strategy for non-ST-segment elevation acute coronary syndrome (NSTEACS). Thus, this study...

Full description

Bibliographic Details
Main Authors: Xiaoping Wu, Ming Guo, Shihua Shi, Shengnan Shi, Yanping Deng, Shenglan Wang, Yabing Wang, Peili Wang, Keji Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Shenqisuxin granule
non-ST-segment elevation acute coronary syndrome
intestinal flora
randomized controlled trial
Chinese herbs
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.888724/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.888724/full

Similar Items